Influence of cannabis use on incidence of psychosis in people at clinical high risk

Aims Evidence for case–control studies suggests that cannabis use is a risk factor for the development of psychosis. However, there have been limited prospective studies and the direction of this association remains controversial. The primary aim of the present study was to examine the association between cannabis use and the incidence of psychotic disorders in people at clinical high risk of psychosis. Secondary aims were to assess associations between cannabis use and the persistence of psychotic symptoms, and with functional outcome. Methods Current and previous cannabis use were assessed in individuals at clinical high risk of psychosis (n = 334) and healthy controls (n = 67), using a modified version of the Cannabis Experience Questionnaire. Participants were assessed at baseline and followed up for 2 years. Transition to psychosis and persistence of psychotic symptoms were assessed using the Comprehensive Assessment of At-Risk Mental States criteria. Level of functioning at follow up was assessed using the Global Assessment of Functioning disability scale. Results During follow up, 16.2% of the clinical high-risk sample developed psychosis. Of those who did not become psychotic, 51.4% had persistent symptoms and 48.6% were in remission. There was no significant association between any measure of cannabis use at baseline and either transition to psychosis, the persistence of symptoms, or functional outcome. Conclusions These findings contrast with epidemiological data that suggest that cannabis use increases the risk of psychotic disorder.

Keywords

Subject (DDC)

330 - Wirtschaft

Project

Event

Exhibition start date

Exhibition end date

Conference start date

Conference end date

Date of the last check

ISBN

ISSN

1440-1819
1323-1316

Language

English

Created during FHNW affiliation

Yes

Strategic action fields FHNW

Publication status

Published

Review

Peer review of the complete publication

Open access category

Hybrid

License

Citation

Chester, L. A., Valmaggia, L., Kempton, M., Chesney, E., Oliver, D., Hedges, E., Klatsa, E., Stahl, D., van der Gaag, M., de Haan, L., Nelson, B., McGorry, P., Amminger, G. P., Riecher-Rössler, A., Studerus, E., Bressan, R., Barrantes-Vidal, N., Krebs, M.-O., Glenthøj, B., et al. (2023). Influence of cannabis use on incidence of psychosis in people at clinical high risk. Psychiatry and Clinical Neurosciences, 77(9), 469–477. https://doi.org/10.1111/pcn.13555

Full item page